Ameneh Koochaki

Ameneh Koochaki

Auto-generated profile, based on publicly available information

Ameneh Koochaki

Department of Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2016 in Oncology Letters
Verified
Journal Article
Open access
PDF file
MMMehdi Manoochehri
Mehdi Manoochehri
NBNasim Borhani
Nasim Borhani
AKAshraf Karbasi
Ashraf Karbasi
AKAmeneh Koochaki
Ameneh Koochaki
BKBahram Kazemi
Bahram Kazemi
Aberrant DNA methylation has been investigated in carcinogenesis and as biomarker for the early detection of colorectal cancer (CRC). The present study aimed to define the methylation status in the regulatory elements of two proapoptotic genes, Fas cell surface death receptor (FAS) and BCL2-associated X protein (BAX). DNA methylation analysis was performed in tumor and adjacent normal tissue using HpaII/MspI restriction digestion and methylation-specific polymerase chain reaction (PCR). The results observed downregulation of the FAS and BAX genes in the CRC tissues compared with the adjacent normal samples. Furthermore, demethylation using 5-aza-2′-deoxycytidine treatment followed by reverse-transcription quantitative PCR were performed on the HT-29 cell line to measure BAX and FAS mRNA expression following demethylation. The 5-aza-2′-deoxycytidine treatment resulted in significant FAS gene upregulation in the HT-29 cell line, but no significant difference in BAX expression. Furthermore, analysis of CpG islands in the FAS gene promoter revealed that the FAS promoter was significantly hypermethylated in 53.3% of tumor tissues compared with adjacent normal samples. Taken together, the results indicate that decreased expression of the FAS gene due to hypermethylation of its promoter may lead to apoptotic resistance, and acts as an important step during colorectal carcinogenesis.

8 September 2020 in Molecular Biology Reports
Verified
Journal Article
Closed access
PDF file
HKHamzeh Karimkhanloo
Hamzeh Karimkhanloo
SMSamira Mohammadi-Yeganeh
Samira Mohammadi-Yeganeh
RHRazie Hadavi
Razie Hadavi
AKAmeneh Koochaki
Ameneh Koochaki
MPMahdi Paryan
Mahdi Paryan

26 March 2021 in Hormone Molecular Biology and Clinical Investigation
Verified
Journal Article
Closed access
SPShaghayegh Pishkari
Shaghayegh Pishkari
RHRazie Hadavi
Razie Hadavi
AKAmeneh Koochaki
Ameneh Koochaki
JRJavad Razaviyan
Javad Razaviyan
MPMahdi Paryan
Mahdi Paryan
SMSamira Mohammadi-Yeganeh
Samira Mohammadi-Yeganeh
Objectives: The aim of the present study was to investigate the expression of AXL and mTOR genes and their targeting microRNAs (miRNAs) including miR-34a and miR-144 in Medullary Thyroid Carcinoma (MTC) cell line, TT, and determine the effect of these two miRNAs on their target genes to introduce new molecular markers or therapeutics. Methods: The expression of miR-34a, miR-144, and their targets genes including AXL and mTOR was evaluated by quantitative Real-time PCR. Luciferase assay was performed to confirm the interaction between miRNAs and their target mRNAs. The expression level of AXL and mTOR was evaluated before and after miRNAs induction in TT cell line compared with Cos7 as control cells. Results: The expression of AXL and mTOR were up-regulated significantly, while miR-34a and miR-144 were down-regulated in TT cell line compared to Cos7. After transduction, the overexpression of miR-34a and 144 caused down-regulation of both genes. Luciferase assay results showed that the mTOR is targeted by miR-34a and miR-144 and the intensity of luciferase decreased in the presence of miRNAs. Conclusions: Based on the results of the present study and since AXL and mTOR genes play a critical role in variety of human cancers, suppression of these genes by their targeting miRNAs, especially miR-34a and miR-144, can be propose as a new strategy for MTC management. However, more studies are needed to approve the hypothesis.

1 April 2022 in Anti-Cancer Agents in Medicinal Chemistry
Verified
Journal Article
Closed access
PDF file
VOVahid F. Omrani
Vahid F. Omrani
AKAmeneh Koochaki
Ameneh Koochaki
SBSahar Behzad
Sahar Behzad
VKVahid Kia
Vahid Kia
PGPeyman Ghasemi
Peyman Ghasemi
SMSamira Mohammadi-Yeganeh
Samira Mohammadi-Yeganeh
Background: Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancer (BC) cases and is a severe type of BC. Since medicinal herbs containing biocompatible substances that are accepted by patient more than chemical therapeutics, they can be considered a safe option for treating BC. Objective: This study evaluated the effect of Sambucus Ebulus (S. ebulus) extract on a model of TNBC. Methods: S. ebulus extract was prepared using petroleum ether, ethyl acetate, and methanol. The petroleum ether extract was fractionated and analyzed using vacuum liquid chromatography and GC-MS, respectively. MDAMB- 231 and MCF-10A were used as TNBC and normal breast cells, respectively. Flowcytometry and MTT assays were performed to evaluate cell cycle, apoptosis, and viability of the cells. Gene expression analysis was performed using RT-qPCR. Nude mouse allograft tumor models were used, and pathological sections were evaluated. Results: The findings indicated that S. ebulus extract remarkably decreased cell proliferation and viability. The extract had no toxicity to the normal breast cells but efficiently killed the cancer cells. Cell cycle- and apoptosisrelated gene expression showed that fraction 4 of S. ebulus extract significantly increased the expression of Bax, Bak, P53, and c-MYC. Conclusion: This study showed satisfactory results of the effect of S. ebulus extract on clearing BC cells both in vitro and in vivo. Thus, S. ebulus extract may be a safe herbal compound for eliminating BC cells without toxicity to host cells.

12 October 2026 in BMC Complementary Medicine and Therapies
Verified
Journal Article
Open access
PDF file
PKPouria Kavousi
Pouria Kavousi
ZLZohreh Lasjerdi
Zohreh Lasjerdi
STSeyyed Javad Seyyed Tabaei
Seyyed Javad Seyyed Tabaei
NTNiloofar Taghipour
Niloofar Taghipour
MKMona Koosha
Mona Koosha
VVVahideh Moin Vaziri
Vahideh Moin Vaziri
Leishmaniasis is a widespread parasitic disease with cutaneous, mucocutaneous, and visceral forms. Despite longstanding recognition, effective treatment re